Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow

Genetic therapy using microRNA-499 (miR-499) was combined with chemotherapy for the advanced treatment of cancer. Our previous study showed that miR-499 suppressed tumor growth through the inhibition of vascular endothelial growth factor (VEGF) production and subsequent angiogenesis. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Ayaka, Asai, Tomohiro, Ryu, Sho, Ando, Hidenori, Maeda, Noriyuki, Dewa, Takehisa, Oku, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730135/
https://www.ncbi.nlm.nih.gov/pubmed/26797645
http://dx.doi.org/10.3390/jcm5010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730135/
https://www.ncbi.nlm.nih.gov/pubmed/26797645
http://dx.doi.org/10.3390/jcm5010010

Ejemplares similares